| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.009 |